Professor Mary MacLeod

Professor Mary MacLeod
Professor Mary MacLeod
Professor Mary MacLeod

BSc MBChB PhD FRCP

Personal Chair (Clinical)

About

Biography

Dr Macleod is a Clinical Pharmacologist with a personal chair (Teaching and Research) at the University of Aberdeen and honorary Consultant Physician within NHS Grampian.  Her clinical work is largely in the area of acute stroke management, hypertension clinics and primary and secondary cardiovascular prevention.  Current research interests include:

Novel imaging markers in stroke and small vessel disease using fast field cycling MRI

Using linked datasets to explore management of stroke including service organisation and secondary prevention

Interactions between stroke and other diseases (e.g. cancer)

Memberships and Affiliations

Internal Memberships

Chair, Clinical Studies Oversight Group

External Memberships

Chair of Scotland A and B Research Ethics Committees

Honorary Deputy Secretary, British and Irish Association of Stroke Physicians

Trustee SHARP (Scottish Heart and Arterial Disease Prevention)

Latest Publications

View My Publications

Teaching

Teaching Responsibilities

Year 5 MBChB OSCE coordinator

Situational Judgement Test lead

Year 1, 3 and 4 Clinical Pharmacology teaching

MSc Clinical Pharmacology: Pharmacovigilance, Medicines Management

Delivers teaching to MSc Cardiovascular and Diabetes, BSc Neurosciences, BSc Genetics

MRCP PACES examiner

Publications

Page 11 of 15 Results 101 to 110 of 150

  • Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke

    Bellenguez, C., Bevan, S., Gschwendtner, A., Spencer, C. C. A., Burgess, A. I., Pirinen, M., Jackson, C. A., Traylor, M., Strange, A., Su, Z., Band, G., Syme, P. D., Malik, R., Pera, J., Norrving, B., Lemmens, R., Freeman, C., Schanz, R., James, T., Poole, D., Murphy, L., Segal, H., Cortellini, L., Cheng, Y., Woo, D., Nalls, M. A., Müller-Myhsok, B., Meisinger, C., Seedorf, U., Ross-Adams, H., Boonen, S., Wloch-Kopec, D., Valant, V., Slark, J., Furie, K., Delavaran, H., Langford, C., Deloukas, P., Edkins, S., Hunt, S., Gray, E., Dronov, S., Peltonen, L., Gretarsdottir, S., Thorleifsson, G., Thorsteinsdottir, U., Stefansson, K., Boncoraglio, G. B., Parati, E. A., Macleod, M. J., The International Stroke Genetics Consortium (ISGC), The Wellcome Trust Case Control Consortium 2 (WTCCC2)
    Nature Genetics, vol. 44, no. 3, pp. 328-333
    Contributions to Journals: Letters
  • Computed tomography and magnetic resonance perfusion imaging in ischemic stroke: definitions and thresholds

    Dani, K. A., Thomas, R. G. R., Chappell, F. M., Shuler, K., MacLeod, M. J., Muir, K. W., Wardlaw, J. M., Translational Medicine Research Collaboration Multicentre Acute Stroke Imaging Study
    Annals of Neurology, vol. 70, no. 3, pp. 384-401
    Contributions to Journals: Articles
  • Procedures to evaluate the importance of dietary polyamines

    Acheampong, P., Macleod, M. J., Wallace, H. M.
    Methods in Molecular Medicine, vol. 720, no. 6, pp. 349-364
    Contributions to Journals: Articles
  • Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

    Callahan, A., Amarenco, P., Goldstein, L. B., Sillesen, H., Messig, M., Samsa, G. P., Altafullah, I., Ledbetter, L. Y., MacLeod, M. J., Scott, R., Hennerici, M., Zivin, J. A., Welch, K. M. A., SPARCL Investigators
    Archives of Neurology, vol. 68, no. 10, pp. 1245-1251
    Contributions to Journals: Articles
  • Improved detection following neuro-eye therapy in patients with post-geniculate brain damage

    Sahraie, A., Macleod, M. J., Trevethan, C. T., Robson, S. E., Olson, J. A., Callaghan, P., Yip, B.
    Experimental Brain Research, vol. 206, no. 1, pp. 25-34
    Contributions to Journals: Articles
  • Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

    Goldstein, L. B., Amarenco, P., Zivin, J., Messig, M., Altafullah, I., Callahan, A., Hennerici, M., MacLeod, M. J., Sillesen, H., Zweiffler, R., Michael, K., Welch, A., SPARCL Investigators
    Stroke, vol. 40, no. 11, pp. 3526-3531
    Contributions to Journals: Articles
  • Perceptual Learning in the Blind Field of Hemianopic Patients

    Saharie, A., MacLeod, M. J.
    49th Annual Meeting of the Society-for-Psychophysiological-Research
    Contributions to Conferences: Abstracts
  • Evaluation of spermine as a biomarker for clinical research in stroke

    Acheampong, P., Wallace, H. M., MacLeod, M. J.
    Contributions to Conferences: Abstracts
  • Pharmacokinetics of blood polyamines after an oral bolus of polyamines

    Acheampong, P., MacLeod, M. J., Wallace, H. M.
    European Association of Clinical Pharmacology and Therapeutics, pp. 122-123
    Contributions to Conferences: Abstracts
  • Retrospective audit of pre-admission warfarin use in acute stroke patients with pre-existing atrial fibrillation

    Elofuke, P., Pickering, G., Shields, L., MacLeod, M. J., Reid, J. M.
    European Journal of Clinical Pharmacology, vol. 105, pp. 35-35
    Contributions to Journals: Abstracts
Show 10 | 25 | 50 | 100 results per page

Refine

Chapters in Books, Reports and Conference Proceedings

Contributions to Conferences

Contributions to Journals

Working Papers